Effect of gabapentin (neurotonin®) on mood and well-being in patients with epilepsy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 3, 1996, Pages 407-417

  Dimond, Kate R ^a   Pande, Atul C ^a   Lamoreaux, Linda ^a   Pierce, Mark W ^a  

^a PFIZER INC   (United States)

Author keywords

Anti convulsant; Gabapentin; Mood; Well being

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; 4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MENTAL PATIENT; MOOD; MULTICENTER STUDY; REVIEW; WELLBEING; ADULT; AFFECT; DRUG EFFECT; FEMALE; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ACETIC ACIDS; ADULT; AFFECT; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; QUALITY OF LIFE;

EID: 0030115818     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(96)00005-X     Document Type: Article

References (34)

1. ABOU-KHALIL, B., MCLEAN, M., CASTRO, O., and COURVILLE, K. (1990) Gabapentin in the treatment of refractory partial seizures. Epilepsia 31(5): 644 (abstract)
2. BRESLOW, M.F., FANKHAUSER, M.P., POTTER, R.L., MEREDITH, K.E., MISIASZEK, J. and HOPE, D.G. (1989) Role of gamma-aminobutyric acid in antipanic drug efficacy. Am. J. Psychiatry 146(3):353-356.
3. CROSS, J.A., CHEETHAM, S.C., CROMPTON, M.R., KATONA, C.L.E. and HORTON, R.W. (1988) Brain GABA binding sites in depressed suicide victims. Psychiatry Res. 26: 119-129.
4. DILSAVER, S.C., SWANN, A.C., SHOAIB, A.M. and BOWER, T.C. (1993) The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. J. Psych. Neurosci. 18(2): 61-66.
5. DODRILL, C.B. (1991) Behavioral effects of anti-epileptic drugs. In: Neurobehavioral Problems in Epilepsy, D.B. Smith, D.M. Treiman, M.R. Trimble, (Eds.). New York: Raven Press.
6. DODRILL, C.B., WILENSKY, A.J., OJEMANN, L.M. and TEMKIN, N.R. (1992) Neuropsychological, mood, and psychosocial effects of gabapentin. Epilepsia 33 (Suppl 3):117-8.
7. ENNA, S.J. (1984) The role of gamma-aminobutyric acid in anxiety. Psychopathology 17: 15-24.
8. FARIELLO, R.G., VARASI, M. and SMITH, M.C. (1995) Valproic acid: Mechanisms of Action. In: Antiepileptic Drugs, R.H. Levy, R.H. Mattson, B.S. Meldrum, (Eds), pp. 581-588, 4th Ed. Raven Press, New York.
9. GALPERN, W.R., MILLER, L.G., GREENBLATT, D.J., SZABO, G.K., BROWNE, T.R. and SHADER, R.I. (1991) Attenuation of alprazolam discontinuation effects by carbamazepine. Biochem. Pharmacol. 42S: S99-S104.
10. GOETZ, E., FEURERSTEIN, T.J. and MEYER, D.K. (1993) Effects of gabapentin on release of gamma-aminobutyric acid-induced GABA accumulation in several regions of rat brain. Artz.-Forschung (Drug Research) 43:636-638.
11. HANDFORTH, A. and TREIMAN, D.M. (1994) Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia 35(5): 1032-1037.
12. HONMOU, O., OVELESE, A. and KOCSIS, J.D. (1994) The novel antiepileptic gabapentin enhances promoted release of GABA in hippocampus. Soc. for Neurosci. Abstracts 20: 1640. (abstract)
13. KASA, K., OTSUKI, S., YAMAMOTO, M., SATO, M., KURODA, H. and OGAWA, N. (1982) Cerebrospinal fluid gamma-amino-butyric acid and homovanillic acid in depressive disorders. Biol. Psychiat. 17: 877-883.
14. KOCSIS, J.D. and HONMOU, O. (1994) Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci. Lett. 169(1-2): 181-184.
15. LLOYD, K.G., THURET, F. and PILC, A. (1985) Upregulation of GABA-B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J. Pharmacol. Exp. Ther. 235:191-199.
16. LOESCHER, W., HONACK, D. and TAYLOR, C.P. (1991) Gabapentin increases amino-oxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci. Lett. 128: 150-154.
17. LUDGATE, J., KEATING, J., O'DWYER, R. and CALLAGHAN, N. (1985) An improvement in cognitive function following polypharmacy reduction in a group of epileptic patients. Acta Neurolog. Scand. 71:448-452.
18. MACDONALD, R.L. (1995a) Carbamazepine: Mechanism of Action. In: Antiepileptic Drugs, R.H. Levy, R.H. Mattson, B.S. Meldrum, (Eds), pp. 491-498, 4th Ed. Raven Press, New York.
19. MACDONALD, R.L. (1995b) Benzodiazepines: Mechanisms of Action. In: Antiepileptic Drugs, R.H. Levy, R.H. Mattson, B.S. Meldrum, (Eds), pp. 695-704, 4th Ed. Raven Press, New York.
20. MCELROY, S.L., KECK, P.E., POPE, H.G. and HUDSON, J.I. (1992) Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J. Clin. Psychopharm. 12: 42S-52S.
21. MOTOHASHI, N. (1992) GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol. Psychiatry 16(4): 571-579.
22. PETTY, F., KRAMER, G.L., FULTON, M., MOELLER, F.G. and RUSH, A.J. (1993) Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacol. 9(2):125-132.
23. PETTY, F. and SHERMAN, A.D. (1981) GABAergic modulation of learned helplessness. Pharmacol. Biochem. Behav. 15:567-570.
24. PRIMEAU, F., FONTAINE, R. and BEAUCLAIR, L. (1990) Valproic acid and panic disorder. Can. J. Psych. 35(3): 249-250.
25. RAGSDALE, D.S., SCHEUER, T. and CATTERALL, W.A. (1991) Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Molec. Pharmacol. 40: 756-765.
26. RAO, M.L., CLARENBACH, P., VAHLENSIECK, M. and KRATZSCHMAR, S. (1988) Gabapentin augments whole blood serotonin in healthy young men. J. Neural Transm. 73: 129-134.
27. REIMANN, W. (1983) Inhibition by GABA, baclofen, and gabapentin of dopamine release from rabbit caudate nucleus: Are there common or different sites of action? Eur. J. Pharmacol. 94:341-344.
28. ROY-BYRNE, P.P., WARD, N.G. and DONNELLY, P.J. (1989) Valproate in anxiety and withdrawal syndromes. J. Clin. Psych. 50S:44-48.
29. SALETU, B., GRUNBERGER, J. and LINZMAYER, L. (1986) Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int. J. Clin. Pharmacol. Ther. Toxicol. 24: 362-373.
30. SATZINGER, G. (1994) Antiepileptics from gamma-aminobutyric acid. Artz-Forsch. (Drug Res) 44: 261-266.
31. SCHLICKER, E., REIMANN, W. and GOTHERT, M. (1985) Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Drug Res. 35: 1347 - 1349.
32. SCHWEIZER, E., RICKELS, K., CASE, W.G. and GREENBLATT, D.J. (1991) Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome. Arch. Gen. Psychiatry 48: 448-452.
33. TAYLOR, C.P., VARTANIAN, M.G., ANDRUSZKIEWICZ, R. and SILVERMAN, R.B. (1992) 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res. 11: 103-110.
34. TAYLOR, C.P. (1995) Gabapentin: Mechanisms of Action. In: Antiepileptic Drugs, R.H. Levy, R.H. Mattson, B.S. Meldrum, (Eds), pp. 829-842, 4th Ed. Raven Press, New York.